6 Firmen mit Ergebnissen für "degrading"

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

75 Ergebnisse für "degrading" unter Somagenetix

No influence of amyloid-beta-degrading neprilysin activity on prion...

... No influence of amyloid-beta- degrading neprilysin activity on prion pathogenesis. Copy Abstract ... No influence of amyloid-beta- degrading neprilysin activity on prion pathogenesis. - Zurich Open ... No influence of amyloid-beta- degrading neprilysin activity on prion pathogenesis. - Zurich Open ... No influence of amyloid-beta- degrading neprilysin activity on prion pathogenesis. - Zurich Open ...

Fungal communities and their association with nitrogen-fixing bacte...

... compositional and functional differences in the WIF communities as a function of exposure. Wood- degrading ... mixotrophic basidiomycetes with limited lignin- degrading capacities had a higher prevalence compared to the ... WIF communities as a function of exposure. Wood- degrading operational taxonomic units (OTUs) such as ... lignin- degrading capacities had a higher prevalence compared to the southern slope. The colder, more ...

Mehr Ergebnisse

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

45 Ergebnisse für "degrading" unter University of Zurich

UZH - Universitärer Forschungsschwerpunkt Ethik - 2008

... Degrading? John Stuart Mill and Others on Decent Work and the Ideal of Bureaucracy" 4. Januar 2008 Erster ... . Januar 2008Vortrag "Is Working for a Boss Inherently Degrading? John Stuart Mill and Others on Decent ...

Human dignity, self-respect, and dependency - Zurich Open Repositor...

... a degrading way. Abstract The paper deals with the question of whether poverty as such violates the ... dependent on others in a degrading way. Statistics Citations 6 citations in Scopus® Communities ... people are dependent on others in a degrading way. Abstract The paper deals with the question of whether ... , insofar as poor people are dependent on others in a degrading way. Statistics Citations Dimensions.ai ...

Mehr Ergebnisse

GlycoEra AG

https://glycoera.com/  

8820 Wädenswil, Einsiedlerstrasse 34

 +41 44 733 85 75
 info@glycoera.com

GlycoEra AG is advancing glycoengineered therapeutics to address unmet medical needs. Despite significant advancements in understanding the role of glycans in human health and diseases, this knowledge has not translated well into therapeutic drug development, a consequence of the limitations and complexities of controlling glycosylation processes. GlycoEra’s platform has overcome these challenges! The CustomGlycan Platform enables glycan-mediated modes of action through the engineering of highly defined specific glycan structures, accessing a novel combinatorial dimension for the treatment of very challenging diseases.

GlycoEra AG

Einsiedlerstrasse 34

8820 Wädenswil

3 Ergebnisse für "degrading" unter GlycoEra AG

GlycoEra – Game-changing protein engineering

... GlycoEra is a leader in degrading circulating and membrane proteins How do our therapeutics work ... degrading circulating and membrane proteins How do our therapeutics work? GlycoEra has been able to ...

... therapeutics based on the innovative platform for degrading extracellular protein targets. I look forward to ... therapeutics based on the innovative platform for degrading extracellular protein targets. I look forward to ...

Mehr Ergebnisse

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

113 Ergebnisse für "degrading" unter ETH Entrepreneurship

The Robben Island Guidelines

... PREVENTION OF TORTURE, CRUEL, INHUMAN OR DEGRADING TREATMENT OR PUNISHMENT IN AFRICA African Commission on ... GUIDELINES AND MEASURES FOR THE PROHIBITION AND PREVENTION OF TORTURE, CRUEL, INHUMAN OR DEGRADING ... PREVENTION OF TORTURE, CRUEL, INHUMAN OR DEGRADING TREATMENT OR PUNISHMENT IN AFRICA African Commission on ... GUIDELINES AND MEASURES FOR THE PROHIBITION AND PREVENTION OF TORTURE, CRUEL, INHUMAN OR DEGRADING ...

Compilation: Torture under International Law

... ................................................................ 4 1.1.2 Convention against Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment ... Cruel, Inhuman or Degrading Treatment or Punishment, 1975 ... ................................................................ 4 1.1.2 Convention against Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment ... Cruel, Inhuman or Degrading Treatment or Punishment, 1975 ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

19 Ergebnisse für "degrading" unter University Hospital Zurich​, Research and Education Office

Microsoft PowerPoint - Nuvolone Amyloisose Netzwerk 20140619_for we...

... Metal ions Proteostasis Extracellular chaperones Organ  dysfunction SAP GAGs Amyloid  degrading ... Extracellular chaperones Organ  dysfunction SAP GAGs Amyloid  degrading  mechanisms Amyloidoses: protein ... Metal ions Proteostasis Extracellular chaperones Organ  dysfunction SAP GAGs Amyloid  degrading ... Extracellular chaperones Organ  dysfunction SAP GAGs Amyloid  degrading  mechanisms Amyloidoses: protein ...

The role of synovial fibroblasts in RA – University Hospital Zurich

... maintained under cell culture conditions and is characterised by increased expression of matrix- degrading ... culture conditions and is characterised by increased expression of matrix- degrading enzymes and pro ...

Mehr Ergebnisse

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

2 Ergebnisse für "degrading" unter Roche Glycart AG

... release of intracellular proteases, glucosidases and other degrading proteins, generating a considerable ... release of intracellular proteases, glucosidases and other degrading proteins, generating a considerable ...

ASH 2021 In-Depth Report: Haemophilia

... therapeutic that acts by binding and degrading the mRNA encoding antithrombin, leading to increased total ... therapeutic that acts by binding and degrading the mRNA encoding antithrombin, leading to increased total ...

Nach oben